Florida Cancer Specialists & Research Institute Announces Pharmacy Leadership Appointments

Longtime Pharmacy Manager Ray Bailey is retiring

FCS Senior Vice President of Pharmacy Services retires

Ray Bailey, BPharm, Rph will retire from FCS at the end of the year.

FCS appoints new pharmacy directors

John Mills, Sree Challa, Austin Cox and Kristen Boykin will assume many of the responsibilities of Senior Vice President of Pharmacy Services upon his retirement.

FORT MYERS, Fla., December 22, 2022 (GLOBE NEWSWIRE) — Ray Bailey, BPharm, RPh, Senior Vice President of Pharmacy Services for Florida Cancer Specialists & Research Institute, LLC (FCS), will retire on December 31, 2022 . Bailey joined the nationwide practice in 2009 and has been instrumental in the development of the comprehensive Pharmacy Services business.

Michael Diaz, President and Managing Physician of FCS, said, “Ray’s influence in establishing Rx To Go, our in-house oral oncolytic specialty pharmacy, introducing biosimilars and guiding the industry standard in quality actions will be his legacy at FCS and benefit our practice come and our patients for years to come.”

“Under Ray’s leadership, FCS has earned recognition for delivering high-quality, high-level pharmacy and disease management services to ensure our patients receive the medications and support they need to achieve optimal outcomes,” said Nathan H. Walcker , Chief Executive Officer of FCS .

FCS is pleased to announce the following appointments to pharmacy leadership:

John Mills, FCS Vice President of Pharmacy & Centralized Procurement, will provide oversight for Rx To Go and be responsible for pharmacy strategy, centralized procurement, practice engagement and business development.
Sree Challa, PharmD, RPh, CPh, Senior Director of Rx To Go will be responsible for overseeing Rx to Go operations on a daily basis.
Austin Cox, PharmD, senior director of trade relations, will oversee pharmacy relationships, drug purchase agreements and business development.
Kristen Boykin, PharmD, BCOP, BCPS, Director of Pharmacy Operations, will expand her responsibilities to include all aspects of pharmacy operations.

“These experienced and capable leaders will ensure FCS remains world-class in providing effective cancer treatment options to our patients,” said Paul Chadwick, FCS Chief Procurement Officer. “They share a true passion and commitment to world-class standards of pharmacy management and quality improvement with a patient-centric, value-driven focus.”

John Mills joined FCS in 2019 as Director of Payer Relations and Business Strategy. He was appointed Senior Director of Pharmacy the following year and was promoted to his current position in July 2021. John has developed and implemented many powerful strategies to ensure organizational effectiveness and has been instrumental in strengthening relationships with payers, resulting in more patient care and eliminating delays in treatment.

Sree Challa provides Rx To Go strategic leadership for the implementation of advanced strategies to drive change and fulfill FCS tactical goals and vision. An accomplished pharmacist with more than 20 years of experience in pharmacy management, policy, risk analysis and process implementation, he has an impressive track record of achievements in challenging organizations to be the best possible while putting the patient first. Sree joined the Rx To Go team in July 2021.

Austin Cox, PharmD, joined FCS earlier this year. He works to build strong relationships with pharmaceutical companies and other commercial partners to meet the needs of FCS physicians and patients. By integrating his pharmacy and medical drug experience, Austin also takes a leadership role in ensuring compliance with pharmacy and medical boards, as well as OSHA and other regulatory standards for safe, efficient, and cost-effective drug use at FCS’s nearly 100 clinical sites .

Kristen Boykin, PharmD, BCOP, BCPS, a talented and respected Oncology Pharmacist, joined FCS in 2018 as a Clinical Oncology Pharmacist. Kristen brought an extensive knowledge of pharmacy and operational excellence to the team and prides herself on providing quality support to FCS clinics and patients. In January 2021, she was promoted to Director of Pharmacy Operations.

###

About Florida Cancer Specialists & Research Institute
Recipient of a national Clinical Trials Participation Award from the American Society of Clinical Oncology (ASCO), the Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past 5 years, the majority of new cancer drugs approved in the US have been in clinical trials involving Florida Cancer Specialists.* Trained at renowned medical schools and research institutes such as Duke, Stanford, Harvard, Emory, MD Anderson , and Memorial Sloan Kettering our doctors are consistently ranked among the top doctors nationwide by US News & World Report.

Florida Cancer Specialists has built a national reputation for excellence reflected in exceptional and compassionate patient care fueled by innovative clinical research, cutting-edge technologies and advanced treatments including targeted therapies, genome-based treatment and immunotherapy. Our values are embodied by our outstanding team of highly qualified and dedicated doctors, clinicians and staff.

*Prior to approval

Attachments

FCS Senior Vice President of Pharmacy Services retires
FCS appoints new pharmacy directors

CONTACT: Michelle Robey, Vice President Marketing Florida Cancer Specialists & Research Institute (813) 767-9398 [email protected] [email protected], Director Corporate Communications Florida Cancer Specialists & Research Institute (847) 280-1740 [email protected]

Disclaimer: The above press release is received pursuant to an agreement with GlobeNewswire. IndiaShorts assumes no editorial responsibility for this.